SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Nephrology Consultation — Madam C. J. Walker

PatientSarah Walker
Date of birth1976-12-23
IdentifiersMRN HR-ET019-SYN; SSN (made up) 000-19-7062
Document date2026-02-23
AuthorDesmond Achterberg, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Albumin in the urine (286 mg/g) and an eGFR of 54 by the race-free CKD-EPI 2021 equation in a 49-year-old woman with high blood pressure readings awaiting ambulatory confirmation, left ventricular hypertrophy on ECG and protein on a dipstick a year ago. Please advise on the cause, any further tests, kidney-protective treatment and her blood pressure target, APOL1 testing, and a monitoring plan that fits a schedule of travel most weeks. [S]

Urgency: Within two weeks, on the day of her two-week visit, so that she makes one trip. [S]

Questions for the consultant:

History of Present Illness

Madam Walker, 49, is seen at the request of Dr. Okonjo-Bell on the day of her two-week visit. She asked to be addressed as Madam Walker. Her ambulatory monitor showed a 24-hour mean of 149/94, daytime 154/98 and night 140/88, and her home readings average 152/96. Her office has sent last year's executive physical: creatinine 1.18 mg/dL and protein 1+ on a dipstick. She has had morning headaches on some days. She has no visible blood in the urine, no foamy urine she has noticed, no swelling, rash, joint pain, mouth ulcers or kidney stones, and takes no NSAIDs, supplements or herbal products. No known family kidney disease; both parents died when she was a child. She asked plainly whether she will need dialysis and said she would take whatever medicines were needed but would not give up her travel. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

4 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Losartan 50 mg oral tablet, one tablet each morningOne tablet each morning, at the same home time when travelingOral route2026-02-23 to 2026-03-09completedS
Empagliflozin 10 mg oral tablet, one tablet each morning; stop on days of vomiting, diarrhea or not eating, and before surgeryOne tablet each morning, with sick-day rulesOral route2026-02-23activeS
Atorvastatin 20 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-02-23activeS

Problems

ProblemClinical statusVerificationCodeProvenance
Elevated blood pressure at intake (166/102 mmHg, average of two readings), first found at a workplace screening; ambulatory monitoring to confirmresolvedconfirmed R03.0S — Synthetic presenting finding, superseded by the confirmed diagnosis at two weeks.
Albumin in the urine (urine albumin-to-creatinine ratio 286 mg/g) with eGFR 54 by the race-free CKD-EPI 2021 equation; she recalls protein in the urine at an executive physical a year ago, and those records are requested; to be repeated and investigatedresolvedconfirmed R80.9S — Synthetic presenting finding, superseded by the kidney diagnosis at two weeks.
Hypertension, stage 2, confirmed by 24-hour ambulatory monitoring (24-hour mean 149/94, daytime 154/98, night 140/88 without the normal nighttime fall), with left ventricular hypertrophy on ECG and mild hypertensive retinopathy; synthetic modern episode linked to her documented high blood pressureactiveconfirmed I12.9S — Synthetic modern diagnosis anchored to the documented hypertension and nephritis.
Chronic kidney disease G3a A2 (eGFR 54 to 55 mL/min/1.73 m2 by the race-free CKD-EPI 2021 equation; albumin-to-creatinine ratio 286 to 294 mg/g; present for more than three months), most likely hypertensive kidney disease; bland urine sediment and normal-sized kidneys on ultrasound; 5-year kidney failure risk 1.6%activeconfirmed N18.31S — Synthetic kidney findings anchored to the documented nephritis and death from kidney disease.
Hyperlipidemia: LDL 174 mg/dL; 10-year ASCVD risk 7.9% by the Pooled Cohort Equations (intermediate)activeconfirmed E78.5S — Synthetic laboratory finding.

Physical Exam

Vital signs recorded on 2026-02-23; see the referring visit's Vital Signs section. [S]

SystemFinding
GeneralWell, articulate and engaged
Vital signsBlood pressure 160/100 and pulse 80, measured by the clinic nurse today
CardiovascularRegular rhythm; sustained apex beat; no bruits
ExtremitiesNo ankle swelling; no rash

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-02-23Albumin/Creatinine [Mass Ratio] in Urine294mg/gBelow 30 mg/g normal (A1); 30 to 300 moderately increased (A2); above 300 severely increased (A3)HighS
2026-02-23Creatinine [Mass/volume] in Serum or Plasma1.21mg/dL0.59-1.04 mg/dLHighS
2026-02-23Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M55mL/min/{1.73_m2}60 or higher (G1 to G2) unless other kidney damage; 45 to 59 is G3aLowS
2026-02-23Calcium [Mass/volume] in Serum or Plasma9.4mg/dL8.6-10.3 mg/dLNormalS
2026-02-23Phosphate [Mass/volume] in Serum or Plasma3.6mg/dL2.5-4.5 mg/dLNormalS
2026-02-23Parathyrin.intact [Mass/volume] in Serum or Plasma58pg/mL15-65 pg/mLNormalS
2026-02-2325-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma31ng/mL30-100 ng/mLNormalS

Assessment

Data reviewed: Dr. Okonjo-Bell's intake note and results: creatinine 1.22 mg/dL, eGFR 54 at intake and 1.21 mg/dL, eGFR 55 today (CKD-EPI 2021, race-free); potassium 4.4 mmol/L; urine albumin-to-creatinine ratio 286 mg/g at intake and 294 mg/g today; urinalysis 1+ protein without blood, bland sediment; calcium 9.4 mg/dL, phosphate 3.6 mg/dL, parathyroid hormone 58 pg/mL, 25-hydroxyvitamin D 31 ng/mL; A1c 5.4%; LDL 174 mg/dL; hemoglobin 12.4 g/dL. ECG: left ventricular hypertrophy by voltage. Kidney ultrasound this morning: right kidney 10.4 cm, left 10.6 cm, normal cortical thickness, mildly increased echogenicity, no hydronephrosis, stones or cysts. Ambulatory and home readings as above; clinic 160/100 today. [S]

Plan of Treatment